Professional Antenatal Infection Markers: Services in South Kensington
Antenatal infection marker testing may help identify potential bacterial, viral, or parasitic infections during pregnancy, providing information to support informed decisions alongside your NHS antenatal care team.
Antenatal infection markers are laboratory-measured biomarkers that indicate the presence or risk of infections during pregnancy. These specialised blood tests help identify potential bacterial, viral, or parasitic infections that may affect maternal health and pregnancy outcomes, supporting informed healthcare decisions throughout pregnancy.
Pregnancy brings numerous changes to the immune system, making comprehensive infection screening an important consideration for expectant mothers. Understanding these markers provides valuable insights into your health status during this important time.
Key Infection Markers Tested During Pregnancy
- Toxoplasma antibodies — indicating exposure to toxoplasmosis
- Rubella immunity status — measuring protective antibody levels
- Cytomegalovirus (CMV) markers — detecting recent or past infection
- Hepatitis B surface antigen — identifying active hepatitis B infection
- HIV antibodies — screening for HIV infection
- Syphilis markers — detecting syphilis infection
- Group B Streptococcus — identifying bacterial colonisation
Practical Insight: These markers work by detecting either the infectious agents themselves or the immune system’s response to them, providing a comprehensive picture of infection status.
TORCH Screening: Comprehensive Infection Assessment
TORCH testing represents a comprehensive approach to antenatal infection screening, examining multiple pathogens simultaneously. The acronym stands for Toxoplasmosis, Other infections, Rubella, Cytomegalovirus, and Herpes.
| Infection | Marker Tested | Significance |
|---|---|---|
| Toxoplasmosis | IgG/IgM antibodies | Indicates recent or past exposure |
| Rubella | IgG antibodies | Confirms immunity status |
| Cytomegalovirus | IgG/IgM antibodies | Detects active or past infection |
| Herpes Simplex | HSV-1/HSV-2 antibodies | Identifies viral presence |
| Hepatitis B | Surface antigen | Screens for active infection |
Women planning pre-conception can also benefit from dedicated toxoplasmosis assessment — our guide to toxoplasmosis screening in pregnancy planning provides focused guidance on this key TORCH infection.
Who Should Consider Antenatal Infection Marker Testing?
High-Risk Categories
- Women with occupational exposure to infections
- Those with international travel history
- Individuals with compromised immune systems
- Women with previous pregnancy complications
- Those living in high-prevalence areas
Practical Insight: Risk assessment is highly individual — factors such as lifestyle, medical history, and geographical location all influence testing recommendations.
Testing Frequency and Timing
First Trimester Testing
- Initial comprehensive screening
- Immunity status verification
- Baseline infection markers
Second Trimester Considerations
- Follow-up testing if initial results suggest concern
- Additional screening for travel-related exposures
- Monitoring of previously identified markers
Third Trimester Focus
- Group B Streptococcus screening
- Re-testing for certain infections in high-risk individuals
- Final assessment before delivery
Understanding Your Results
- Negative: No evidence of current infection or immunity
- Positive IgG only: Suggests past infection and likely immunity
- Positive IgM: May indicate recent or current infection
- Indeterminate: Requires further testing or monitoring
All results require professional interpretation within the context of your individual health picture and pregnancy circumstances. For broader antenatal health monitoring, consider exploring antibody screening in antenatal care which covers complementary testing approaches.
NHS vs Private Testing Options
| Aspect | NHS Provision | Private Services |
|---|---|---|
| Cost | Free at point of care | Fee-based testing |
| Timing | Scheduled appointments | Flexible timing |
| Test Range | Standard screening panel | Extended marker options |
| Results | Standard reporting | Detailed analysis |
Women who engage in proactive antenatal infection testing often also benefit from monitoring other reproductive health biomarkers. Our guide to understanding CA-125 and ovarian health indicators covers another important dimension of women’s reproductive health surveillance.
Frequently Asked Questions
What do antenatal infection markers test for?
These markers screen for various infections that can potentially affect pregnancy, including toxoplasmosis, rubella, cytomegalovirus, hepatitis B, HIV, and other pathogens that may impact maternal or pregnancy health. Our dedicated resource on HIV testing as a key component of antenatal care packages explains how this marker fits into comprehensive antenatal screening.
When should antenatal infection marker testing be performed?
Testing typically occurs during the first trimester as part of initial antenatal assessment, with additional testing performed based on individual risk factors, symptoms, or exposure history throughout pregnancy.
What’s the difference between IgG and IgM antibodies in results?
IgG antibodies typically indicate past infection and potential immunity, whilst IgM antibodies may suggest recent or current infection, though interpretation requires professional assessment of individual circumstances.
Are antenatal infection marker tests safe during pregnancy?
These tests involve simple blood collection procedures that are considered safe throughout pregnancy, with no known risks to maternal health or pregnancy development.
Do I need antenatal infection marker testing if I feel well?
Many infections can be present without obvious symptoms, particularly in early stages, making screening valuable even when feeling well, especially given pregnancy’s impact on immune function.
Medical Disclaimer
This content is for educational purposes only and does not constitute medical advice, diagnosis, or treatment recommendations. Private infection marker testing is intended to complement, not replace, NHS antenatal care. All pregnant women should engage with their NHS midwifery and obstetric team, who provide the full standard of antenatal monitoring required during pregnancy. Any concerns about infections, pregnancy health, or test results should always be discussed with your midwife, GP, or obstetrician. Results from private testing must be interpreted by a qualified healthcare professional within your complete clinical context.